Opportunity
Federal Register #2026-19840
DEA Revokes Registration of Christopher Nadorff, M.D. Due to Suspended Medical License
Buyer
Drug Enforcement Administration
Posted
September 29, 2026
Identifier
2026-19840
This notice announces an administrative action by the Drug Enforcement Administration (DEA), part of the Justice Department. - DEA has revoked Certificate of Registration No. FN4962761 for Christopher Nadorff, M.D. - Action is based on the suspension of Dr. Nadorff's Ohio medical license - Dr. Nadorff is no longer authorized to handle controlled substances in Ohio - DEA denies any pending applications for renewal, modification, or additional registration by Dr. Nadorff - No products, services, OEMs, or vendors are involved in this action - The notice is strictly administrative and does not relate to procurement or acquisition activities
Description
This notice pertains to the decision and order involving Christopher Nadorff, M.D., issued by the Department of Justice and the Drug Enforcement Administration. The order revokes Dr. Nadorff's DEA Certificate of Registration No. FN4962761 due to the suspension of his Ohio medical license, which renders him unauthorized to handle controlled substances in Ohio. The revocation is effective October 29, 2026, and any pending applications to renew or modify his registration are denied. The document is part of the Federal Register volume 91, pages 61443-61444, published on September 29, 2026.